Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism
- PMID: 38835911
- PMCID: PMC11007627
- DOI: 10.1515/medgen-2022-2135
Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism
Abstract
X-linked dystonia-parkinsonism (XDP) is a neurodegenerative movement disorder that primarily affects adult Filipino men. It is caused by a founder retrotransposon insertion in TAF1 that contains a hexanucleotide repeat, the number of which differs among the patients and correlates with the age at disease onset (AAO) and other clinical parameters. A recent work has identified additional genetic modifiers of age-associated penetrance in XDP, bringing to light the DNA mismatch repair genes MSH3 and PMS2. Despite X-linked recessive inheritance, a minor subset of patients are female, manifesting the disease via various mechanisms such as homozygosity, imbalanced X-chromosome inactivation, or aneuploidy. Here, we summarize and discuss clinical and genetic aspects of XDP, with a focus on variable disease expressivity as a consequence of subtle genetic differences within a seemingly homogenous population of patients.
Keywords: X-linked dystonia-parkinsonism (XDP); age-related penetrance; genetic modifiers; repeat-length polymorphism; retrotransposon insertion.
© 2022 the author(s), published by De Gruyter.
Figures



Similar articles
-
X-linked dystonia-parkinsonism: over and above a repeat disorder.Med Genet. 2022 Jan 12;33(4):319-324. doi: 10.1515/medgen-2021-2105. eCollection 2021 Dec. Med Genet. 2022. PMID: 38835428 Free PMC article.
-
A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.Ann Neurol. 2019 Jun;85(6):812-822. doi: 10.1002/ana.25488. Epub 2019 May 3. Ann Neurol. 2019. PMID: 30973967
-
Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset.Brain. 2023 Mar 1;146(3):1075-1082. doi: 10.1093/brain/awac160. Brain. 2023. PMID: 35481544 Free PMC article.
-
X-Linked Dystonia-Parkinsonism.2005 Dec 13 [updated 2018 Feb 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2005 Dec 13 [updated 2018 Feb 15]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301662 Free Books & Documents. Review.
-
X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.Acta Neurol Belg. 2023 Feb;123(1):45-55. doi: 10.1007/s13760-022-02144-3. Epub 2022 Nov 23. Acta Neurol Belg. 2023. PMID: 36418540 Review.
Cited by
-
Genetic Landscape of Dystonia in Asian Indians.Mov Disord Clin Pract. 2025 May;12(5):594-601. doi: 10.1002/mdc3.14325. Epub 2025 Jan 3. Mov Disord Clin Pract. 2025. PMID: 39749944
References
-
- Lee LV, Rivera C, Teleg RA. et al. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, “Lubag”) Int J Neurosci. 2011;121(Suppl 1):3–11. - PubMed
-
- Lee LV, Kupke KG, Caballar-Gonzaga F. et al. The phenotype of the X-linked dystonia-parkinsonism syndrome: An assessment of 42 cases in the Philippines. Medicine. 70:179–87. - PubMed
-
- Pauly MG, Ruiz López M, Westenberger A. et al. Expanding Data Collection for the MDSGene Database: X-linked dystonia-parkinsonism as use case example. Mov Disord. 2020;35:1933–8. - PubMed
-
- Westenberger A, Reyes CJ, Saranza G. et al. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism. Ann Neurol. 2019;85(6):812–22. - PubMed
-
- Pasco PMD, Ison CV, Muňoz EL. et al. Understanding XDP through imaging, pathology, and genetics. Int J Neurosci. 2010;121:12–7. - PubMed
LinkOut - more resources
Full Text Sources